Publication | Closed Access
Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance
70
Citations
20
References
2020
Year
NanomedicineHealth SciencesBcl-2 InhibitorPolymer-drug ConjugateMedicinePharmacotherapyAnti-cancer AgentCancer-specific Prodrug NanoparticleTumor TargetingPharmacologyRadiation OncologyDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1